mofiltration in critically ill patients with a high risk of bleeding.
in recent years, been increasingly employed for the manBackground. Systemic heparinization is associated with a agement of acute renal failure in critically ill patients high rate of bleeding when used to maintain patency of the [1] [2] [3] [4] [5] [6] . Although improvement in survival rates compared extracorporeal circuit during continuous renal replacement with intermittent hemodialysis (IHD) has not been therapy (CRRT) in critically ill patients. Regional anticoagulation can be achieved with citrate, but previously described proven, CRRT is frequently chosen for patients who do techniques are cumbersome and associated with metabolic not tolerate IHD because of hemodynamic instability.
complications.
Pump-assisted venovenous techniques such as continu-
Methods. We designed a simplified system for delivering ous venovenous hemofiltration (CVVH) are now preregional citrate anticoagulation during continuous venovenous ferred over arteriovenous techniques because of signifihemofiltration (CVVH). We evaluated filter life and hemorrhagic complications in the first 17 consecutive patients who cantly greater solute clearances and lower rates of received this therapy at our institution. Blood flow rate was vascular complications [7] [8] [9] .
set at 180 ml/min. Ultrafiltration rate was maintained at 2.0
One of the main disadvantages with CRRT is the reliters/hr and citrate-based replacement fluid (trisodium citrate quirement for anticoagulation in order to prevent clot- 13 .3 mm, sodium chloride 100 mm, magnesium chloride 0.75 ting of the extracorporeal circuit. Heparin has been the mm, dextrose 0.2%) was infused proximal to the filter to mainmost frequently used anticoagulant, but is associated tain the desired fluid balance. Calcium gluconate was infused through a separate line to maintain a serum-ionized calcium with a risk of life-threatening hemorrhagic complications level of 1.0 to 1.1 mm.
as high as 25 to 30% [3, 10, 11] . In addition, heparinResults. All patients were critically ill and required mechaniinduced thrombocytopenia may preclude the use of hepcal ventilation and vasopressor therapy. Systemic heparin antiarin in some cases (abstract; Chong and Jacques, Intencoagulation was judged to be contraindicated in all of the sive Care Med 16:437, 1990) [13] . Although the use of patients. A total of 85 filters were used, of which 64 were lost because of clotting, with a mean life span of 29.5 Ϯ 17.9 hours. frequent saline flushes without the use of anticoagulant
The remaining 21 filters were discontinued for other reasons.
has been reported by Paganini to increase the duration of Control of fluid and electrolyte balance and azotemia was excelthe CRRT circuit patency [14] , others have experienced lent (mean serum creatinine after 48 to 72 hr of treatment was frequent clotting of filters with this technique [3, 11] . reduced risk of bleeding, including regional heparinizaConclusion. Our simplified technique of regional anticoagution [15] , low molecular weight heparin [16] Figure 1A . The previously 4:368, 1993) [10, 11] . Citrate causes anticoagulation by reported design of regional citrate anticoagulation with chelation of ionized calcium in the extracorporeal circuit.
CAVHD by Mehta et al is illustrated in Figure 1B for However, systemic anticoagulation does not occur as the comparison [10] . ionized calcium level is restored when blood returning Vascular access was established by insertion of a doufrom the extracorporeal circuit mixes with venous blood. tems, Minneapolis, MN, USA). The filters were primed Although citrate anticoagulation has been shown to with two liters of isotonic saline containing 10,000 U/liter be effective and safe in CRRT, previously described of heparin. In patients with heparin-induced thrombocytosystems are cumbersome and have been associated with penia, priming was performed without heparin. Blood metabolic complications [10, 11] . It has been widely flow rate was maintained at 180 ml/min as measured claimed that citrate cannot be used safely with hemofilafter dilution with the replacement fluid. A Travenol 6300 tration alone (CVVH) because of insufficient clearance volumetric infusion pump (Baxter Healthcare) was set of sodium citrate from the blood, resulting in derangeto maintain a constant ultrafiltration rate at 2 liter/hr. ments of serum sodium and bicarbonate concentrations.
The ultrafiltrate was measured hourly and replaced by It has been felt that dialysis (diffusive clearance) is necescontinuous infusion with a citrate-based replacement sary for adequate removal of citrate, as well as the sofluid to maintain the desired fluid balance. The replacedium load caused by the hypertonic trisodium citrate [4, ment fluid contained trisodium citrate 13.3 mmol/liter (40 11, 22, 23]. However, we have designed a simple and mEq/liter), sodium chloride 100 mmol/liter, magnesium safe system for delivering regional citrate anticoagulachloride 0.75 mmol/liter (1.5 mEq/liter), and 0.2% dextion during CVVH. To investigate the efficacy and safety trose ( Table 1 ). The replacement fluid was infused proxiof our technique, we evaluated extracorporeal circuit mal to the filter at a rate dependent on the volume of patency and hemorrhagic complications in the first 17 other parenteral solutions administered and the net fluid consecutive patients with renal failure and a high risk of removed. Filters were flushed every four hours with 200 bleeding who received this form of therapy in the intenml of 0.9% saline. Filters were changed for suspected sive care units (ICUs) at our institution. We found our clotting if the ultrafiltration rate decreased to approxitechnique of regional citrate anticoagulation to be simmately 1500 ml/hr for more than two consecutive hours. ple, effective, and safe in this high-risk population. The serum-ionized calcium level was checked prior to initiation of CVVH, and if necessary, calcium gluconate METHODS was infused until the ionized calcium was greater than 1.0 mmol/liter. During CVVH, calcium was infused through a Patients separate line at a rate determined by a sliding scale. We retrospectively studied the first 17 adult patients Twenty grams of calcium gluconate in one liter of D5W with renal failure who were treated with a new method was infused at 70 ml/hr for an ionized calcium of 0.9 to of regional citrate anticoagulation with CVVH in the 1.0 mmol/liter, 60 ml/hr for an ionized calcium of 1.0 to ICUs at the Massachusetts General Hospital from Au-1.1 mmol/liter, and 50 ml/hr for an ionized calcium of gust 1995 through May 1996. The modality of renal re-1.1 to 1.3 mmol/liter. The median rate of calcium infusion placement therapy (RRT) was selected by the attending was 60 ml/hr, which provided 2.8 mmol/hr (5.6 mEq/ hr). nephrologist. In addition to CVVH, many patients also Three patients received an equivalent sliding scale using received IHD at other times during their hospitalization.
calcium chloride instead of calcium gluconate. Potassium Fourteen patients also received heparin anticoagulation and magnesium were supplemented as needed. with RRT (including IHD) at other times during their ICU course. Medical records were reviewed to obtain Monitoring of therapy information on demographic factors, diagnosis, etiology Serum electrolytes and arterial blood gases were moniof renal failure, APACHE II illness severity score [24] at tored every 6 to 12 hours or more frequently if needed. the time of ICU admission, contraindication to heparin, Serum-ionized calcium was measured every six hours or hemofilter life span, metabolic and coagulation paramemore often if indicated, and serum total calcium was ters, hemorrhagic episodes, other complications of CVVH, and survival. measured daily. The nephrology coverage was notified 
RESULTS
Clinical features for an ionized calcium below 0.9 or greater than 1. 3 The clinical characteristics of the 17 patients are shown mmol/liter. A complete blood count, coagulation paramin Table 2 . There were 7 male and 10 female patients. eters, phosphate, blood urea nitrogen, and creatinine
The mean age was 58.2 Ϯ 19.5 (Ϯ sd) years. Twelve of were monitored at least daily. Activated clotting times the 17 patients were postoperative. Eleven had cardiac or (ACTs) were not monitored routinely. We did not meamajor vascular surgery, and one underwent a Whipple's sure solute clearance rates during this study. However, procedure. All 17 patients had circulatory failure with prior to this study, we determined the urea and creatinine vasopressor dependency. All of the patients also reclearances provided by our CVVH technique. Clearquired mechanical ventilation. The mean APACHE II ances were calculated by dividing the ultrafiltrate conscore at the time of ICU admission was 25.6 Ϯ 7.5 (N ϭ centration by the serum concentration and multiplying 16). Fourteen patients had acute renal failure, and all were severely oliguric or anuric. One of these 14 patients by the ultrafiltration rate. Urea clearance was between 25 and 28 ml/min, and creatinine clearance was between had acute renal failure in a functioning renal allograft with a baseline serum creatinine of 1.3 mg/dl. Three 19 and 23 ml/min (data not shown). APACHE II scores are at the time of admission to ICU (many were higher at the time of initiation of CVVH). Patients 10, 11, and 12 were on chronic dialysis. All other patients had acute renal failure. Most patients also received additional forms of RRT at other times during their ICU course. Abbreviations are: M, male; F, female; AVR, aortic valve replacement; MVR, mitral valve replacement; ASD, atrial septal defect; CABG, coronary artery bypass grafting; DIC, disseminated intravascular coagulation; CRF, chronic renal failure; GI, gastrointestinal; D, died; S, survived. patients (10, 11, and 12) had chronic renal failure and 143.1 Ϯ 136.3 hours. Sixty-four filters (75.3%) were lost because of clotting at a mean filter life of 29.5 Ϯ 17.9 were on maintenance dialysis. Fluid overload was the most common indication for initiating RRT. In all cases, hours. The rate of citrate replacement fluid infusion varied hourly, depending on the volume of other parenteral CVVH was chosen as the RRT modality because of solutions administered, the net fluid removed, and the hemodynamic instability. Heparin anticoagulation was achieved rate of ultrafiltration. The average infusion rate judged to be contraindicated because of ongoing or reof citrate replacement fluid was 1.4 liters per hour, which cent hemorrhage in 11 patients, severe thrombocytois equivalent to 18.6 mmol/hr of citrate. This provides 2.0 penia and/or coagulopathy in 4 patients, and recent mammol of citrate per liter of blood in the extracorporeal jor surgery in 2 patients. Four patients had developed circuit. We did not find an increase in clotting associated severe complications during RRT with heparin anticoagwith hours of relatively low rates of citrate infusion due ulation and were switched from heparin to citrate anticoto high rates of infusions of other solutions. If the low agulation. Three of these patients had suffered liferate of citrate infusion was due to a low rate of achieved threatening bleeding episodes, and one had developed ultrafiltration, then clotting was usually imminent. The heparin-induced thrombocytopenia. Five patients briefly use of 21 filters was discontinued for other reasons than received CVVH with saline flushes without anticoaguclotting (catheter problems, performance of diagnostic lant therapy but were converted to citrate anticoagulatests or surgical procedures, discontinuation of RRT, or tion because of frequent clotting. patient's death).
Efficacy
Control of fluid and electrolyte balance and azotemia was excellent in all 17 patients (Table 3 ). The mean Data on filter life were available for 85 filters from 15 patients. Two patients were excluded from this part of serum creatinine after 48 to 72 hours of treatment was 2.4 mg/dl Ϯ 1.2 (N ϭ 16) despite severe oliguria or anuria the analysis because of inadequate information in their medical records. The total duration of citrate CVVH in all patients. Acid-base balance was well controlled except for two episodes of worsening metabolic acidosis therapy was 2374 hours, and the mean duration was in order to keep the complexity as low as possible. Like low serum-ionized calcium levels (with an elevated seseveral other investigators [3, 11] , we had poor experirum total calcium level in one), together with exacerbaence with frequent saline flushes, without anticoagulation of metabolic acidosis with a high serum anion gap.
tion. Patient 8 had septic shock caused by meningococcemia, An adequate concentration of citrate in the extracorand patient 13 had fulminant hepatic failure and candida poreal circuit is necessary to chelate calcium in sufficient sepsis. Serum-ionized calcium levels fell to 0.7 and 0.8 amounts to prevent clotting. We administered citratemmol/liter, respectively, and did not correct despite inbased replacement fluid containing 13.3 mmol/liter of travenous infusion of large doses of calcium (18 and 81 trisodium citrate at an average rate of 1.4 liter/hr. The mEq over 12 hr, respectively) in addition to the calcium net rate of citrate administration was, therefore, 18.6 infusion determined by the sliding scale. Neither patient mmol/hr. A blood flow rate of 180 ml/min measured had a significant change in clinical status attributable to after the infusion of the replacement fluid produces a the hypocalcemia. In both cases, the replacement fluid citrate concentration in the extracorporeal circuit of 2.0 was changed to a fluid containing bicarbonate instead of mmol/liter of blood. Mehta et al used 4% trisodium citrate, and CVVH was carried out in the absence of citrate (140 mmol/liter), which was infused at an initial anticoagulant. Both patients had improvement of the rate of 170 ml/hr (range 110 to 210 ml/hr), resulting ionized calcium level and the high anion gap metabolic in 24 mmol/hr (range 18.0 to 28.2 mmol/hr) of citrate acidosis after discontinuation of the citrate anticoagulaadministered. The blood flow rate is not specified in their tion. All other patients had stable serum calcium levels.
reports, but citrate was administered at 3 to 8% of blood No other significant complications occurred during the flow, giving a predicted range of citrate concentration treatment. No patient developed metabolic alkalosis or of approximately 4.2 to 11.2 mmol/liter of extracorporeal hypernatremia.
blood. Thus, when compared with our system, Mehta's Outcome technique involves a greater amount of citrate administered per liter of blood, which results in longer durations The outcome for each patient is shown in Table 2 .
of hemofilter patency. However, similar levels of blood Nine of the 17 patients (53%) survived to be discharged citrate concentration can be achieved with our system from the hospital. Among the survivors, six out of seven by reducing the blood flow to rates similar to those used patients with acute renal failure recovered their renal by Mehta et al or by increasing the rates of ultrafiltration function, but one patient continued to require dialysis. and replacement fluid administration. We have recently Most of the patients who died had supportive measures been using a blood flow rate of 120 ml/min (measured withdrawn because of persistent multiorgan failure. The after replacement fluid infusion), which should provide mean APACHE II score at the time of ICU admission further prolongation of filter life without appreciable was 20.9 Ϯ 5.2 for survivors (N ϭ 8) and 30.2 Ϯ 6.7 for effect on the solute clearance rates. those who died (N ϭ 8) .
We have used a fixed rate of ultrafiltration and varied the rate of replacement fluid administration to maintain DISCUSSION fluid balance. This approach leads to variation in the The results show that our design of regional citrate ratio of citrate to blood on an hourly basis. Although we did not observe an increase in clotting during hours anticoagulation for use with CVVH is effective and can of relatively low rates of citrate replacement fluid infufailure and sepsis. Inadequate metabolism of citrate to sion, it is possible that these hours contributed to partial bicarbonate presumably led to accumulation of citrate clotting, which, in turn, may have led to a shorter filter and resulted in systemic chelation of calcium, manifested life. An alternative approach would be to set a fixed rate by low levels of serum-ionized calcium in both patients of citrate replacement fluid infusion that would provide with a high serum total calcium level in one. There was more consistent regional anticoagulation. Fluid balance an exacerbation of the high anion gap metabolic acidosis could then be maintained by adjusting the ultrafiltration in these patients, probably because bicarbonate producrate as desired. Currently, we are unable to use this tion from citrate metabolism did not keep up with the design because of limitations of our ability to control loss of bicarbonate through the filter [21] . These findings the ultrafiltration rate by the equipment we are currently were recognized early in both patients, and they were employing.
switched to a replacement solution containing bicarbonIn the system described by Mehta et al, the infusion ate before there was any alteration in their clinical status. of concentrated sodium citrate must be counterbalanced Although citrate toxicity is rare, patients must be moniby using an appropriate amount of hypotonic, bicarbontored closely for this potential complication. We curate free dialysate. Alkali and sodium balances are depenrently check ionized calcium levels every four hours at dent on dialysis efficiency, which may be inconsistent.
the beginning of therapy. Subsequently, the frequency They have reported a high rate of metabolic alkalosis of monitoring ionized calcium can be individualized (25 to 38%) requiring treatment with hydrochloric acid based on the status of the patient. [10, 11] . In contrast, we infuse an isotonic solution with
The 53% survival rate in our group of patients is at a citrate concentration set to be similar to the concentraleast comparable to what generally has been achieved tion of alkali in standard dialysis solutions (40 mEq/ in critically ill patients with acute renal failure [29, 30]. liter). There is no apparent risk of metabolic alkalosis This is intriguing in view of the fact that all the patients or hypernatremia associated with our system, and we did were severely ill, as is illustrated by the high ICU admisnot observe these complications in any of our patients.
sion APACHE II scores. Furthermore, many of the paHowever, our system requires a high infusion rate of tients deteriorated appreciably from the time of ICU replacement fluid in order to administer sufficient citrate admission to the time of initiation of CVVH. However, for anticoagulation. This demands a high rate of ultrafilthe survival of our patients is not directly comparable tration for maintenance of fluid balance. Therefore, a to previous studies of acute renal failure in critically ill filter with a high ultrafiltration coefficient must be used.
patients, as our study includes patients with chronic renal This high rate of ultrafiltration also results in the high failure. Finally, our study lacks a control group, which clearances we achieve.
makes it unsuitable for determining the impact of citrate We did not monitor solute clearance rates routinely.
anticoagulation on survival in comparison with other Rather, we monitored the ultrafiltration rate hourly, and methods of anticoagulation. clotting was suspected when the ultrafiltration rate was
In most respects, the performance of our system is persistently low. It is well known that ultrafiltration rates similar to that described by Mehta et al. However, our fall with a longer duration of membrane use, possibly system is considerably less complex. First, only a single because of fiber clotting or because of an intrinsic propreplacement solution is employed without the use of erty of the membrane [27, 28] . However, studies have dialysate. In contrast, the technique used by Mehta et shown that sieving coefficients are preserved up to a al requires separate citrate and saline infusions as well mean of 43 hours during hemofiltration (abstract; Golper as a hypotonic, bicarbonate free dialysate. Second, their et al, J Am Soc Nephrol 3:367, 1992). Thus, as long technique requires close monitoring for metabolic alkaas ultrafiltration is maintained, clearance rates are also losis and hypernatremia and treatment of these complimaintained.
cations when they occur. These complications are not No hemorrhagic episodes occurred during citrate antiassociated with our system. coagulation in this high-risk population, which confirms Currently, the main drawback of citrate-CRRT is the previous reports on the safety of regional citrate anticocost of customized production of the citrate solution. agulation in CRRT (abstract; Mehta et al, J Am Soc
With advances in CRRT equipment and standardization Nephrol 4:368, 1993) [11] . No effect on coagulation paof protocols, we believe that the demand for citrate solurameters was observed. In contrast, three of our patients tions will grow and will soon be enough to attract manuhad developed severe bleeding complications during anfacturers. ticoagulation with heparin. Furthermore, one patient had
We conclude that our simplified technique of regional developed heparin-induced thrombocytopenia.
citrate anticoagulation with CVVH is practical and effecEvidence of citrate toxicity occurred in two of our tive and can be used safely in critically ill patients with patients. Both patients had severe lactic acidosis, one from meningococcal sepsis and the other because of liver a high risk of bleeding.
